NCT04492956View on ClinicalTrials.gov

Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

October 2, 2020

Primary Completion Date

March 7, 2022

Study Completion Date

April 4, 2022

Conditions
Childhood-Onset Fluency Disorder (Stuttering)
Interventions
DRUG

Ecopipam

Oral tablet

DRUG

Placebo

Oral tablet

Trial Locations (9)

11235

Social Psychiatry Research Institute, Brooklyn

30341

Institute For Advanced Medical Research, Atlanta

32256

Clinical Neuroscience Solutions Inc, Jacksonville

32801

Clinical Neuroscience Solutions Inc, Orlando

38119

Clinical Neuroscience Solutions Inc, Memphis

48824

Michigan State University, East Lansing

66208

Social Psychiatry Research Institute, Prairie Village

92501

UC Riverside, Riverside

92705

CI Trials, Santa Ana

Sponsors
All Listed Sponsors
collaborator

University of California, Riverside

OTHER

collaborator

Premier Research Group plc

UNKNOWN

lead

Emalex Biosciences Inc.

INDUSTRY